| answer text |
<p>In developing its policy on cannabis-based products for medicinal use, the Government
looked at approaches taken by other countries to learn from their experience. Broadly
two approaches have been taken: to regulate as a medicine (both licenced and unlicensed)
as in the United Kingdom or to regulate outside of the medicinal regime as in Canada.
In reviewing the available international evidence, the Chief Medical Officer for England
and Chief Medical Adviser to the UK Government, looked at evidence reviews from the
United States, Ireland, Australia, and the World Health Organization. Departmental
officials have also reviewed information from a wide range of other countries and
have spoken to the authorities and organisations in Australia, Canada, Denmark, the
Netherlands, and the United States (New York).</p>
|
 |
